Xin X, Cai Y, Matsumoto K, Agui T
Institute for Animal Experimentation, University of Tokushima School of Medicine, Japan.
Endocrinology. 1995 Jan;136(1):132-7. doi: 10.1210/endo.136.1.7828523.
Endothelin (ET) produced by endothelial cells has recently been found to be a potent vasoconstricting hormone. In this paper, ET isopeptides, both ET-1 and ET-3, were shown to be potent stimulators of interleukin (IL)-6 production by a rat aortic endothelial cell clone, WAE-1. Semi-quantitative polymerase chain reaction analysis indicated that augmentation of IL-6 production is due to an increase in IL-6 messenger RNA level. Ligand binding assay indicated that most of the [125I]ET-1 binding sites correspond to ET receptor type A (ETAR). However, ET receptor type B (ETBR) was shown to be also present on this cell line by reverse transcription polymerase chain reaction using ETBR-specific primers and by ligand binding assay using [125I]ET-3, although the protein receptor level is much lower than that of ETAR. ET-1, but not ET-3, induced inositol 1,4,5-triphosphate production and an increase in intracellular Ca2+ concentration with similar dose response. These data suggest that ET-1 stimulates IL-6 production through ETAR-phospholipase C activation axis, whereas ET-3 stimulates IL-6 production through different signaling pathway. The results shown in this paper raise the possibility that ET plays a role in inducing inflammation in endothelium.
内皮细胞产生的内皮素(ET)最近被发现是一种强效的血管收缩激素。在本文中,ET-1和ET-3这两种ET异肽被证明是大鼠主动脉内皮细胞克隆WAE-1产生白细胞介素(IL)-6的强效刺激物。半定量聚合酶链反应分析表明,IL-6产生的增加是由于IL-6信使核糖核酸水平的升高。配体结合试验表明,大多数[125I]ET-1结合位点对应于A型ET受体(ETAR)。然而,通过使用ETBR特异性引物的逆转录聚合酶链反应以及使用[125I]ET-3的配体结合试验表明,该细胞系上也存在B型ET受体(ETBR),尽管其蛋白受体水平远低于ETAR。ET-1而非ET-3以相似的剂量反应诱导肌醇1,4,5-三磷酸的产生以及细胞内Ca2+浓度的升高。这些数据表明,ET-1通过ETAR-磷脂酶C激活轴刺激IL-6的产生,而ET-3通过不同的信号通路刺激IL-6的产生。本文所示结果增加了ET在内皮细胞炎症诱导中起作用的可能性。